Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Sciele Pharma has announced that the FDA has approved benzyl alcohol lotion 5%, the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects.
Subscribe to our email newsletter
Sciele has acquired from Summers Laboratories the rights to this novel, patented product in the US, Canada and Mexico. The company expects to launch the product in the third quarter of 2009.
Ed Schutter, president and COO of Sciele Pharma, said: “We are excited to introduce this novel product to the prescription head lice treatment market. This product will meet the unmet need for an effective treatment that does not contain a neurotoxic chemical and addresses possible resistance issues. The approval of this new head lice product marks an important milestone for Sciele’s pediatric portfolio.”